Navigation Links
Using Gradient PCR to determine the optimum annealing temperature.

ificity of a PCR reaction. In most cases, this temperature must be empirically tested. The PCR is normally started at 5C below the calculated temperature of the primer melting point (Tm). However, the possible formation of unspecific secondary bands shows that the optimum temperature is often much higher than the calculated temperature (>12C).

Further PCR reactions with gradually increasing temperatures are required until the most stringent conditions have been found. When a standard PCR cycler is used, this method is the most time-intensive optimization strategy.

The Mastercycler gradient now enables rapid testing of the optimum temperature conditions on one block and in one experiment. During the PCR, a temperature gradient, which can be programmed between 1C and 20C, is built up across the thermoblock. This allows the most stringent parameters for every primer set to be calculated with the aid of only one single PCR reaction.

If the gradient function is not used, the block offers precise homogeneity, thus ensuring first-class reproducible results.

Example for Gradient PCR Program
'"/>

Source:


Page: All 1 2

Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Oil-Free PCR Using the Hot Top Assembly
3. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. Using XL1-Red Mutator Strain to Generate Esterase Variants
6. Detect Released Oligosaccharides Using the Eagle Eye II Still Video Imaging System
7. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
8. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
9. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
10. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
11. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Using Gradient PCR determine the optimum annealing temperature

(Date:11/5/2009)...TRANSPORTATION -- Gone hybrid . . . , Fuel eco...es are now posted at the www.fueleconomy.gov web...ed and maintains for the U.S. Department of Energy...e of the top 10 vehicles on the best fuel economy ... (51 MPG city; 48 highway). "This list proves that...
(Date:11/5/2009)... RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstC...ading supplier of innovative products for processi...sults for the first quarter of fiscal 2010. ,, ...any reported revenues of $5.2 million, a 15 percen...rst quarter a year ago. The Company said the key c...
(Date:11/5/2009)... FORT WORTH, Texas, Nov. 5 /PRNewswire-FirstCall/ ...nounced today that it has entered into a Letter of...of Virtual Health Technologies, Inc. (OTC Bulletin...id $1,000,000 in cash and debt, 4,000,000 shares o...ted by WNDM on the Veriscrip technology being acqu...
(Date:11/5/2009)... Drug safety specialty firm Bi...rning and Informatics earned the Certified Profess...edential from the American Society for Training an...helle Flewell has more than fifteen years of medic...nce and is responsible for the development of the ...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4
...rushing into the adoption of electronic medical re...cern for data security? , ,The question has been r...e some bills seek to provide incentives to encoura...ords, and others that raise privacy concerns are c...Moreover, headline-grabbing data breaches in both ...
...Corp. has been awarded a Phase II SBIR grant wort...logy for clinical research and possible diagnostic...nce company engaged in gene therapy and the study ...rom the National Institute of General Medical Sci...ween Mirus Bio scientist Mary Anne Watt and Gregor...
...al knows the missing link in many software evaluat...the implementation. , ,Cagigal, chief information ...d technologists who miscalculate return on investm... costs, which will exceed the implementation cost ...al It,s easy to pinpoint the pre-implementation c...
Other Biology Technology:Privacy, trust still the biggest barriers to electronic record sharing 2Privacy, trust still the biggest barriers to electronic record sharing 3The business case for software applications 2The business case for software applications 3
(Date:11/4/2009)...s out, hold the power to help militaries and munit...p toxic waste on test sites. , Compounds known a... in World War II and have been used in military mu...are often used to propel tank shells and act like ...reased knowledge of their environmentally harmful ...
(Date:11/4/2009)...s received more than $10 million in research grant...l stimulus program, bringing thetotal amount of st...illion. Thirty-three projects achieved stimulus f...ther. , "The university has thoughtfully underta...larly excellence to federal agency priorities. Th...
(Date:11/4/2009)...FirstCall/ -- Quest Diagnostics Incorporated (NYSE...ic testing, information and services, announced th... income from continuing operations rose to $192 mi...on, or $0.81 per diluted share, for the third quar...educed by a $0.03 per share charge associated with...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Unprecedented Merger Occurs in Retained Physician Search Industry 47441 1Unprecedented Merger Occurs in Retained Physician Search Industry 47441 2Unprecedented Merger Occurs in Retained Physician Search Industry 47441 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 1Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 2Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 4Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 5Religious devotion does not impact abortion decisions of young unwed women 47440 1Religious devotion does not impact abortion decisions of young unwed women 47440 2
...ng held by plants has been revealed by Howard Hugh...y, which builds on more than a decade of painstaki...different types of plant tissues, shows clearly fo...e research, conducted by Sigal Savaldi-Goldstein a...anne Chory at The Salk Institute for Biological St...
... at Johns Hopkins have discovered how cells fine-t...nt is available at the moment. , Too little oxygen...power it, so when oxygen is scarce, cells appear t...fficient substitute that "is specialized to keep t... out of gas," says Gregg Semenza, M.D., Ph.D., a p...
...ndred years after the first vitamin was named, wha...ficial, standardized recommendations for public he...or, and director of the Nutrition and Neurocogniti...on Research on Aging (USDA HNRCA) at Tufts Univers...titutes of Health State-of-the- Science Conference...
Other Biology News:Researchers learn what sparks plant growth 2Researchers learn what sparks plant growth 3Need oxygen? Cells know how to spend and save 2Vitamins: Science doesn't always match policy 2
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Rhodamine Conjugated from Biomeda Corporation
Goat Anti-Human Presenilin 2 Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-TWIK-2 (Kcnk6, TOSS) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: